| Literature DB >> 29085346 |
Tien-Huang Lin1,2, Cheng-Yin Tseng3,4, Yi-Chyi Lai5, Chien-Chen Wu6, Chun-Fa Huang3,6, Ching-Ting Lin3,6.
Abstract
In Klebsiella pneumoniae, we have previously shown that IscR, an Fe-S cluster-containing transcriptional factor, plays a dual role in controlling capsular polysaccharide biosynthesis and iron-acquisition systems by switching between its holo and apo forms. In this study, the effect of IscR on type 3 fimbriae expression and biofilm formation was investigated. We found that production of the major subunit of type 3 fimbriae, MrkA, was increased in the ΔiscR and iscR3CA strains, a strain expressing a mutant IscR that mimics apo-IscR, at both the translational and transcriptional levels. Based on the fact that type 3 fimbriae expression is the major factor affecting biofilm formation, increased biofilm formation was also found in ΔiscR or iscR3CA, suggesting that holo-IscR represses biofilm formation. However, the repression of type 3 fimbriae expression by IscR is indirect. To further understand the regulatory mechanism of IscR, the effect of IscR on the expression of mrkHIJ, which encodes cyclic di-GMP (c-di-GMP)-related regulatory proteins that control type 3 fimbriae expression, was studied. We found that holo-IscR could directly repress mrkHI transcription, indicating that MrkHI is required for IscR regulation of type 3 fimbriae expression. Finally, deletion of iscR attenuated K. pneumoniae virulence in a peritonitis model of mouse infection, while the absence of the [2Fe-2S] cluster of IscR had no effect on K. pneumoniae virulence during infection. Taken together, our results demonstrate the underlying mechanism of the [2Fe-2S] cluster of IscR in controlling type 3 fimbriae expression and its effect on K. pneumoniae pathogenesis.Entities:
Keywords: IscR; Klebsiella pneumoniae; MrkHI; biofilm formation; type 3 fimbriae
Year: 2017 PMID: 29085346 PMCID: PMC5650617 DOI: 10.3389/fmicb.2017.01984
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Bacterial strains and plasmids used in this study.
| Strains or plasmids | Descriptions | Reference or source |
|---|---|---|
| CG43S3 | CG43 Smr | |
| Δ | CG43S3Δ | |
| CG43S3 | ||
| Δ | CG43S3Δ | |
| Δ | CG43S3Δ | This study |
| Δ | CG43S3Δ | |
| Δ | CG43S3Δ | |
| Δ | CG43S3Δ | |
| Δ | CG43S3Δ | |
| Δ | CG43S3Δ | This study |
| BL21(DE3) | New England Biolabs | |
| S17-1 | ||
| pmrkAZ15 | Cmr, 402-bp fragment containing the region upstream of | |
| pmrkHIZ15 | Cmr, 405-bp fragment containing the region upstream of | |
| pIscR | Cmr, 980-bp fragment containing an | |
| pIscR3CA | Cmr, 980-bp fragment containing C92A, C98A and C104A mutant allele of | |
| pET30b-IscR | Kmr, 654-bp fragment encoding full-length IscR cloned into pET30b | |
| pET30b-IscR3CA | Kmr, 654-bp fragment encoding full-length C92A, C98A and C104A mutant allele of |
Primers used in this study.
| Primer | Sequence (5′→3′) | Enzyme cleaved | |
|---|---|---|---|
| GT288 | CGGATCCAGACAAAATGGAGGGAACCCTA | ||
| GT289 | CAGATCTTACTGGTCTTTATCGTTCCCTC | ||
| GT290 | GCAATAGCAACATTCTGATTGG | ||
| GT342 | AATGAGAGAACGATCGTCGATCA | ||
| GT345 | TTATCCTTCGACCGGTCTCC | ||
| GT348 | AGATCCTACAAATGGGGCGT | ||
| GT349 | TCCTCAATATTTGCCTGGAA | ||
| RT11 | GGTAGGGGAGCGTTCTGTAA | 67 | 23S rRNA |
| RT12 | TCAGCATTCGCACTTCTGAT | ||
| RT29 | TAAGCAAACTGGGCGTGAA | 20 | |
| RT30 | TAGCCCTGTTGTTTGCTGGT | ||
| GT46 | GTTTAAGTTCCGCCATCTCG | 120 | |
| GT47 | TTGCGCTTGGCTTCTAAGAT | ||
| GT42 | AGTTATGCCGATGTCATCCAT | 59 | |
| GT43 | GATTCTGATGGCAGAAATATCCTT | ||
| GT54 | TTTCGAGGTAACCGAAAACG | 84 | |
| GT55 | GAGGTATCCTGTGGGCTCTG | ||